In the absence of key macroeconomic releases on Wednesday, the sour market sentiment is likely to keep demand for equities subdued, as investors await US GDP and Jobless Claims figures on Thursday and ...

Dow Jones futures hover around 46,450 during European hours on Thursday, ahead of the United States (US) session opening.

A Trump administration decision to repurpose an old chemotherapy drug for autism has surprised many experts — including the ...

ProKidney shows strong Phase 2 CKD data, FDA support, and cash runway, with key readouts ahead despite single-asset risks. See why PROK stock is a buy.

Brand Authenticity, Generation Z, Consumer Loyalty, Digital Engagement, Structural Equation Modeling, Emerging Markets, Ghana Ofosu-Boateng, I. and Jose, L.M. (2025) Exploring the Impact of Brand ...

Below is Validea's guru fundamental report for BLOOM ENERGY CORP (BE). Of the 22 guru strategies we follow, BE rates highest using our Quantitative Momentum Investor model based on the published ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

When President Donald Trump’s administration announced it would repurpose an old, generic drug as a new treatment for autism, ...

Sarepta Therapeutics faces major risks in 2025 with stock collapse, halted therapies, and financial woes. Click here to read ...

A new study found that most people who experience major cardiovascular events had modifiable risk factors, contradicting with ...

Here’s an analysis of the letter bearing Donald Trump’s name that was included in a 50th birthday book for Jeffrey Epstein. The Wall Street Journal in July reported on the 2003 birthday book and ...